Studies that involve the use of Recombinant DNA or potentially Pathogenic agents in human subjects must be reviewed and approved by the Institutional Biosafety Committee (IBC).
Investigators who intend to submit a human pathogen or gene transfer protocol to the Johns Hopkins Institutional Review Board (IRB) should contact the Biosafety Officer for IBC submission details.
Health, Safety, and Environment News and Announcements ALERTS Updated Policy - HSE 505 - Acquisition and Use of Select Agents & Toxins (1/30/12) Updated Policy - HSE 809 - Laboratory Exit/Decommission and Clearance Policy (1/30/12) Updated Policy - HSE 031 - Handling of Hazardous Drugs (12/19/11) NEWS Safety - Updated Protective Devices Table (1/9/12) Updated Policy - HSE policies have been reviewed, updated and approved by the Joint Committee (9/28/11) |
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts
